DRREDDY's weekly performance was disappointing, with a return of -3.93% and a Sharpe Ratio of -0.71, indicating poor risk-adjusted returns. The stock's volatility was moderate at 22.26%, but its Max Drawdown was also -3.93%, suggesting a high level of risk. Compared to its peers, DRREDDY underperformed SUNPHARMA and HINDUNILVR, but outperformed DIVISLAB. Overall, the stock was relatively risky this week.

[Volatility: 22.26%]